Stannous Fluoride "Mild" Staining Characterization Sought In Plaque Report
This article was originally published in The Tan Sheet
Executive Summary
Data on the effectiveness of stannous fluoride against gingivitis that minimize the dental staining potential of the ingredient should be included in the final report being prepared by FDA's Dental Products Plaque Subcommittee, Procter & Gamble requests in Nov. 23 comments to the group.
You may also be interested in...
Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
FDA's advance notice of proposed rulemaking for OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register
Antigingivitis/Antiplaque Combination With Other Actives Excluded In ANPR
FDA's advance notice of proposed rulemaking for OTC antigingivitis/antiplaque products excludes the combination of antigingivitis/antiplaque ingredients with other oral health care ingredients. The 1notice was published in the May 29 Federal Register
Zinc Citrate Clinical Data Support Category I Efficacy - Colgate
Data from a double-blind, stratified, six-month clinical study on the efficacy of zinc citrate in reducing plaque and gingivitis supports Category I classification of the ingredient, Colgate-Palmolive states.